Further, oncology development revenues are expected to remain depressed during the third quarter due to stay-at-home orders and patients’ deferral of appointments. The Sequencing Services portfolio has been registering a fall in revenues on lower IVD licensing over the past few months. However, softness within the DTC (direct-to-consumer) market is expected to have dented the company’s array business in the third quarter, as was the case in the last-reported quarter.
![dartmouth computer gene construction kit dartmouth computer gene construction kit](https://www.researchgate.net/profile/Devin-Balkcom/publication/2924026/figure/fig2/AS:669005215969286@1536514681796/Some-level-sets-of-the-Hamiltonian-and-corresponding-extremals-for-a-vehicle-with-a_Q320.jpg)
Notably, the robust customer adoption of its COVIDSeq Test (which is a high-throughput sequencing-based in vitro diagnostic or IVD workflow enabling the detection of SARS-CoV-2) is likely to have further driven the company’s top line. Also, the company is upbeat about the accelerating adoption of comprehensive genomic profiling and the next-generation sequencing tests.
Dartmouth computer gene construction kit software#
Illumina’s TruSight Software Suite, launched in July to accelerate and facilitate the adoption of whole-genome sequencing, is likely to have contributed to the third quarter revenues. The launch of NovaSeq 6000 v1.5 Reagent Kit in August to make whole genome sequencing more accessible and affordable for labs of all sizes is likely to have boosted the company’s third-quarter revenues as well.
![dartmouth computer gene construction kit dartmouth computer gene construction kit](https://www.embopress.org/cms/asset/50a1f52c-7fa1-4399-951c-39797b2f3562/embj2020104948-fig-0002-m.jpg)
With the economy gradually returning to normal, these trends are expected to have continued during the third quarter as well, thus boosting the top line. Oncology testing was still below pre-COVID-19 levels, but improving. However, it is encouraging to note that the clinical business has been resilient despite the pandemic-led challenges, driven by reproductive health, per the company.
![dartmouth computer gene construction kit dartmouth computer gene construction kit](http://www.itavi.ca/wp-content/uploads/2014/10/Depositphotos_10919598_m-31.jpg)
This is likely to have weighed on the company's quarterly performance. Further, the company also apprehended that the impact of the extended closures or reduced operations at some universities and research institutes might continue in the third quarter as well. Illumina, during its second-quarter earnings call in early August, had confirmed that its top line was hampered due to prolonged closures and reduced operations at research laboratories along with temporary reallocation of resources to polymerase chain reaction testing for COVID-19.